Antenatal glucocorticoid treatment is not associated with long-term metabolic risks in individuals born before 32 weeks of gestation

Autor: M J J, Finken, M G, Keijzer-Veen, F W, Dekker, M, Frölich, F J, Walther, J A, Romijn, B J, van der Heijden, J M, Wit, G J, van Steenbrugge
Přispěvatelé: Pediatric surgery, ICaR - Ischemia and repair, Other departments, Other Research, Neonatology, General Paediatrics, Plastic, Reconstructive and Hand Surgery, Pediatrics
Jazyk: angličtina
Rok vydání: 2008
Předmět:
Zdroj: Archives of Disease in Childhood-Fetal and Neonatal Edition, 93(6), F442-F447. BMJ Publishing Group
Finken, M J J, Keijzer-Veen, M G, Dekker, F W, Frolich, M, Walther, F J, Romijn, J A, van der Heijden, B J & Wit, J M 2008, ' Antenatal glucocorticoid treatment is not associated with long-term metabolic risks in individuals born before 32 weeks of gestation ', Archives of Disease in Childhood-Fetal and Neonatal Edition, vol. 93, no. 6, pp. F442-F447 . https://doi.org/10.1136/adc.2007.128470
Archives of disease in childhood. Fetal and neonatal edition, 93(6), F442-F447. BMJ Publishing Group
Archives of Disease in Childhood. Fetal and Neonatal Edition, 93, 442-447. BMJ Publishing Group
ISSN: 1359-2998
Popis: BACKGROUND: A single course of maternal glucocorticoid treatment is effective in reducing neonatal mortality after preterm birth. However, in animals, maternal glucocorticoid treatment is associated with lifelong hyperglycaemia and hypertension, and impaired nephrogenesis in offspring. Findings from studies in humans on this topic are highly contradictory due to a number of methodological flaws, and renal function after glucocorticoid exposure has never been assessed. OBJECTIVES: To assess in individuals born
Databáze: OpenAIRE